First-Line Therapy in Ovarian Cancer Trials
Authors:
- Tate ThigpenTTTate Thigpen
- Andreas DuboisADAndreas Dubois
- Jessica McAlpineJMJessica McAlpine
- Philip DiSaiaPDPhilip DiSaia
- Keiichi FujiwaraKFKeiichi Fujiwara
- William HoskinsWHWilliam Hoskins
- Gunnar KristensenGKGunnar Kristensen
- Robert MannelRMRobert Mannel
- Maurie MarkmanMMMaurie Markman
- Jacobus PfistererJPJacobus Pfisterer
- Michael QuinnMQMichael Quinn
- Nick ReedNRNick Reed
- 1 April 2011
- journal article
- review article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 21 (4) , 756-762
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Phase II Evaluation of Pemetrexed in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian or Primary Peritoneal Carcinoma: A Study of the Gynecologic Oncology GroupJournal of Clinical Oncology, 2009
- Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: A Gynecologic Oncology Group studyGynecologic Oncology, 2006
- A phase II study of docetaxel in paclitaxel-resistant ovarian and peritoneal carcinoma: a gynecologic oncology group studyGynecologic Oncology, 2003
- Recurrent Epithelial Ovarian Carcinoma: A Randomized Phase III Study of Pegylated Liposomal Doxorubicin Versus TopotecanJournal of Clinical Oncology, 2001
- Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel.Journal of Clinical Oncology, 1998
- Altretamine (Hexamethylmelamine) in Platinum-Resistant and Platinum-Refractory Ovarian Cancer: A Gynecologic Oncology Group Phase II TrialGynecologic Oncology, 1998
- Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study.Journal of Clinical Oncology, 1998
- Activity of Gemcitabine in Patients with Advanced Ovarian Cancer: Responses Seen Following Platinum and PaclitaxelGynecologic Oncology, 1996
- Phase II study of vinorelbine in patients with pretreated advanced ovarian cancer: activity in platinum-resistant disease.Journal of Clinical Oncology, 1996
- A Phase II Trial of 5-Fluorouracil and High-Dose Leucovorin in Recurrent Epithelial Ovarian CarcinomaAmerican Journal of Clinical Oncology, 1995